Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

NCT02935608 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02935608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Lead sponsor
Biogen
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
August 6, 2018
Enrollment
502 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

lumbosacral radiculopathy